Oncotelic Therapeutics, Inc. Capital Expenditures
Oncotelic Therapeutics, Inc. (OTLC) reported Capital Expenditures of $13.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2017-03-30.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2017-03-30
- Oncotelic Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2015-12-31 was -$1.00K.
- Oncotelic Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2015-09-30 was -$1.00K.
- Oncotelic Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2015 was $13.00K, a 23.53% decline from fiscal 2014.
- Oncotelic Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2014 was $17.00K.
- Oncotelic Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2009 was $109.00K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2015-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | -$2.00K derived: sum of 2 quarters · filed 2017-03-30 | $13.00K 10-K · filed 2017-03-30 | |
| 2015-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $14.00K 10-Q · filed 2016-11-14 | ||
| 2015-06-30 | $15.00K 10-Q · filed 2016-08-02 | |||
| 2014-12-31 | $17.00K 10-K · filed 2016-03-25 | |||
| 2009-12-31 | $109.00K 10-K · filed 2012-03-28 |